{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:23:11Z","timestamp":1781950991892,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/19\/19\/34175"],"award-info":[{"award-number":["FS\/19\/19\/34175"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T032448\/1"],"award-info":[{"award-number":["MR\/T032448\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["225868\/Z\/22\/Z"],"award-info":[{"award-number":["225868\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["220283\/Z\/20\/Z"],"award-info":[{"award-number":["220283\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000308","name":"British Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.hrthm.2024.06.033","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:54:46Z","timestamp":1718988886000},"page":"2445-2454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential interactions between medications for rate control and direct oral anticoagulants: Population-based cohort and case-crossover study"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-7333","authenticated-orcid":false,"given":"Angel Y.S.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Warren-Gash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Leyrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.06.033_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.033_bib2","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/CIRCULATIONAHA.111.019919","article-title":"Rate control in atrial fibrillation: targets, methods, resynchronization considerations","volume":"124","author":"Heist","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.06.033_bib3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bcp.12541","article-title":"Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor","volume":"79","author":"Frost","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2024.06.033_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12959-018-0183-3","article-title":"Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study","volume":"16","author":"Sennesael","year":"2018","journal-title":"Thromb J"},{"key":"10.1016\/j.hrthm.2024.06.033_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.06.033_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cjco.2021.11.002","article-title":"Amiodarone, verapamil, or diltiazem use with direct oral anticoagulants and the risk of hemorrhage in older adults","volume":"4","author":"Hill","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.hrthm.2024.06.033_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3593","article-title":"Association of oral anticoagulants and verapamil or diltiazem with adverse bleeding events in patients with nonvalvular atrial fibrillation and normal kidney function","volume":"3","author":"Pham","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2024.06.033_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025723","article-title":"Concomitant use of diltiazem with direct oral anticoagulants and bleeding risk in atrial fibrillation","volume":"11","author":"Xu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2024.06.033_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jth.13614","article-title":"The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population","volume":"15","author":"Holm","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2024.06.033_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ehjcvp\/pvad070","article-title":"Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study","volume":"9","author":"Grymonprez","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hrthm.2024.06.033_bib11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11239-020-02037-3","article-title":"The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding","volume":"49","author":"Hanigan","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hrthm.2024.06.033_bib12","first-page":"629","article-title":"Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients","volume":"66","author":"Shurrab","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.06.033_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2022.10.031","article-title":"Association between concurrent use of amiodarone and DOACs and risk of bleeding in patients with atrial fibrillation","volume":"186","author":"Shurrab","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2024.06.033_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/M22-3238","article-title":"Risk for bleeding-related hospitalizations during use of amiodarone with apixaban or rivaroxaban in patients with atrial fibrillation: a retrospective cohort study","volume":"176","author":"Ray","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2024.06.033_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1060028018795140","article-title":"Clinical safety outcomes in patients with nonvalvular atrial fibrillation on rivaroxaban and diltiazem","volume":"53","author":"Bartlett","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hrthm.2024.06.033_bib16","doi-asserted-by":"crossref","first-page":"573.e1","DOI":"10.1016\/j.amjmed.2017.11.047","article-title":"Efficacy and safety outcomes of direct oral anticoagulants and amiodarone in patients with atrial fibrillation","volume":"131","author":"Lupercio","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2024.06.033_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.hrthm.2014.03.006","article-title":"Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial","volume":"11","author":"Steinberg","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.06.033_bib18","article-title":"Combination of rivaroxaban and amiodarone increases bleeding in patients with atrial fibrillation","volume":"13","author":"Wang","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.hrthm.2024.06.033_bib19","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cpt.2369","article-title":"Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study","volume":"110","author":"Gronich","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2024.06.033_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.hrthm.2024.06.033_bib21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/pds.4996","article-title":"Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism","volume":"29","author":"Jick","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hrthm.2024.06.033_bib22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hrthm.2024.06.033_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0962280217713032","article-title":"Propensity score analysis with partially observed covariates: how should multiple imputation be used?","volume":"28","author":"Leyrat","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.hrthm.2024.06.033_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs","volume":"275","author":"Sturmer","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.hrthm.2024.06.033_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.hrthm.2024.06.033_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/EDE.0000000000000944","article-title":"The case-crossover design for drug-drug interactions: considerations for implementation","volume":"30","author":"Bykov","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.hrthm.2024.06.033_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2020.07.054","article-title":"The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants","volume":"195","author":"Lee","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.hrthm.2024.06.033_bib28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2024.3867","article-title":"Serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban","volume":"331","author":"Ray","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.06.033_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjcard.2017.05.026","article-title":"Efficacy and safety of rivaroxaban versus warfarin in patients taking nondihydropyridine calcium channel blockers for atrial fibrillation (from the ROCKET AF Trial)","volume":"120","author":"Washam","year":"2017","journal-title":"Am J Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124028078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:53:05Z","timestamp":1732715585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124028078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1547527124028078"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.033","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential interactions between medications for rate control and direct oral anticoagulants: Population-based cohort and case-crossover study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}